Update on improving tick-borne disease therapy from Dr Petersen.
Update on 9/11 Surveillance Study from Dr Otto.
Update on treatment of B-cell lymphoma from Dr Breen.
Update on targeting epigenome for treatment of B-cell lymphoma from Dr McCleary-Wheeler.
Update on clinical trial for hemangiosarcoma treatment from Dr. Dickerson.
Research Update from Dr. Trepanier looking at environmental chemical exposure and cancer.
Update for research to train pathologists to support Golden Retriever Lifetime Study.
Research update from Dr. Volk on prognostic markers for canine mammary cancer.
Continue reading “Research Update Mid-Year 2 CHF 02489: Tumor-permissive Collagen Signatures in Canine Mammary Gland Tumors: Development of Prognostic Markers and Targeted Therapies for Improved Outcomes”
FINAL update from Dr. Arenas indicating a potential vaccine for canine brucellosis has been developed and tested in the laboratory on blood samples. The next step to get this vaccine to market would be to test on actual live dogs.
Dr. Casal and her fellow researchers at UPENN are pleased to report their data now provides them with a marker test for Puppy Eye Syndrome. UPENN will be able to offer this gene test to breeders the beginning of 2020. Prices will be announced before the end of the year.
Additional details of this exciting development in their work are provided in their end-year 2 research update.